α‐Defensin Inhibits Influenza Virus Replication by Cell‐Mediated Mechanism(s)
Citations Over TimeTop 10% of 2007 papers
Abstract
The innate immune system mounts the first host response to pathogens. Because alpha-defensins, which are cationic antimicrobial peptides of polymorphonuclear neutrophils and other leukocytes, are important effectors of the innate immune system, we studied the antiviral activity of human alpha-defensin-1 (also known as "human neutrophil peptide-1" [HNP-1]) against influenza virus in vitro. Treatment of cell cultures with HNP-1 soon after infection resulted in marked inhibition of influenza virus replication and viral protein synthesis. This effect was not due to cytotoxicity or to a direct effect on the virus. Treatment of cells with HNP-1 followed by its removal before infection also inhibited viral replication, suggesting that the inhibition was due to the modulation of cellular pathways. HNP-1 treatment inhibited protein kinase C (PKC) activation in infected cells, suggesting the involvement of the PKC pathway. Our data expand the previously known activity of alpha -defensins against influenza virus. Characterizing the mechanism of action of alpha -defensins may lead to the identification of new strategies for prevention and therapy.
Related Papers
- → Mouse Beta-Defensin-14, an Antimicrobial Ortholog of Human Beta-Defensin-3(2008)53 cited
- → Dysregulation of human beta-defensin-3 expression in the peripheral blood of patients with sepsis(2021)5 cited
- → Differential expression of α‐ and β‐defensins in human peripheral blood(2003)76 cited
- → Down regulation of defensin genes during SARS-CoV-2 infection(2022)16 cited
- → Mouse beta defensin-1 is a functional homolog of human beta defensin-1(1998)86 cited